Relationship between anamnestically assessed physical activity and baroreflex sensitivity after anthracycline;Vztah mezi anamnesticky zjištěnou tělesnou aktivitou a baroreflexní senzitivitou po léčbě antracykliny

Cesko-Slovenska Pediatrie

Volumn 55, Issue 5, 2000, Pages 281-287

  Hrstkova H ^a   Honzikova N ^a   Fiser B ^a   Zavodna E ^a   Novotny J ^a  

^a NONE

Author keywords

Anthracycline therapy; Baroreflex; Leukaemia; Physical activity

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CALCULATION; CARDIOTOXICITY; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; HUMAN; LEUKEMIA; PHYSICAL ACTIVITY; PRESSORECEPTOR REFLEX; PULSE RATE; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE;

EID: 0034069146     PISSN: 00692328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Adamcová, M., Geršl, V., Hrdina, R., Palička, V., Mazurová, Y.: Contribution to prediction and pathogenesis of daunorubicin-induced cardiomyopathy in rabbits. Exp. Clin. Cardiol., 3, 1998, č. 3, s. 179-183.
2. Ainsworth, B. E., Haskell, W. L., Leon, A. S., Jacobs, D. R. Jr., Montoye, H. J., Sallis, J. F., Paffenbarger, R. S. Jr.: Compendium of physical activities: classification of energy costs of human physical activities. Med. Science Sports Exercise, 25, 1993, č. 1, s. 71-80.
3. Al-Kubati, M. A. A., Fišer, B., Sieglová, J.: Baroreflex sensitivity during psychological stress. Physiol. Res., 46, 1997, s. 27-33.
4. Butera, G., Piciacchia, D., Chesa, M., Condoluci, C. et al.: Evaluation of late cardiotoxicity of anthracycline in childhood. Minerva pediat., 50, 1998, č. 4, s. 111-119.
5. Butera, G., Piciacchia, D., Chessa, M., Condoluci, C., Tornesello, A., Delogu, A. B., Mastrangelo, S., Cipriani, A.: Valutazione della cardiotossicita tardiva da antracycline in eta pediatrica. Minerva pediat., 50, 1998, č. 4, s. 111-119.
6. Elbl, L., Vášová, I., Chaloupka, V., Hájek, R., Vorlíček, J.: Zhodnocení kardioprotektivního účinku ICRF-187-Cardioxane u nemocných léčených antracykliny. Vnitř. Lék., 42, 1996, č. 4, s. 268-273.
7. Fišer, B., Honzíková, N., Semrád, B., Nováková, Z.: Aging and baroreflex sensitivity. Fundament, clin. Pharmacol., 12, 1998, s. 74.
8. Geršl, V., Bajgar, J., Krs, O., Hrdina, R., Palička, V., Mazurová, Y.: Changes in cholinesterase activities after daunorubicin administration to rabbits. Hum. experiment. Toxicol., 15, 1996, s. 834-838.
9. Geršl, V., Hrdina, R.: Noninvasive polygraphic cardiac changes in daunorubicin - induced cardiomyopathy in rabbits. Shorn, věd. Prací lék. Fak. Hradci Králové, 37, 1994, č. 2, s. 49-55.
10. Grenier, M. A., Lpshutz, S. E.: Epidemiology of anthracycline cardiotoxicity in children and adults. Semin. Oncol., 25. 1998, č. 4. s. 72-85.
11. Gribbin, B., Pickering, E. C., Sleight, P., Peto, R.: Effect of age and high pressure on baroreflex sensitivity in man. Circ. Res., 29. 1971, s. 424-431.
12. Honzíková, N., Fišer, B., Honzík, J.: Noninvasive determination of baroreflex sensitivity in man by means of spectral analysis. Physiol. Res., 41, 1992, s. 31-37.
13. Honzíková, N, Semrád, B., Fišer, B.: Baroreflex sensitivity and heart rate variability in patients after myocardial infarction: efect of thrombolytic therapy. In: Measurement of Heart Rate and Blood Pressure Variability in Man (Eds. A. J. Man in't Veld, G. A., van Montfrans, G. J., Langewouters, K. I., Lie, G. Mancia), Van Zuiden Communications B. V. Amsterdam, 1995, s. 113-117.
14. Hrstková, H., Novotný, J., Brázdová, Z., Bajer, M.: Antropometrické ukazatele u dětí a adolescentů po léčbě zhoubného nádoru. Čs. Pediat., 53, 1998, č. 12, s. 744-747.
15. Hrstková, H., Novotný, J., Nečas, J.: Některé parametry tělesné zdatnosti u děti po terapii zhoubného nádoru antracykliny s kardioprotekcí. Čs. Pediat., 52, 1997, č. 9, s. 679-682.
16. La Rovere, M. T., Specchia, G., Mortara, A. et al.: Baroreflex sensitivity, clinical correlates and cardiovascular mortality among patients with a first myocardial infarction. Circulation, 59, 1987, s. 256-262.
17. Maeda, A., Honda, M., Kuramochi, T., Takabatake, T.: Doxorubicin cardiotoxicity: diastolic cardiac myocyte dysfunction as a result of impaired calcium handling in isolated cardiac myocytes. Jpn. Circ. J.,62, 1998,č. 7, s. 505-511.
18. Nohl, H., Gille, L., Staniek, K.: The exogenous NADH dehydrogenase of heart mitochondria is the key enzyme responsible for selective cardiotoxicity of anthracyclines. Naturforsch, 53, 1998, č. 3-4, s. 279-285.
19. Pagani, M., Somers, V., Furlan, R., Dell' Orto, S., Conway, J., Baselli, G., Cerutti, S., Sleight, P., Malliani, A.: Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension, 12, 1988, č. 6, s. 600-610.
20. Sakai, T., Inagki, R., Taniguchi, T., Shinozuka, K., Kunitomo, M., Hayashi, N., Ishii, Y., Muramatsu, I.: Persistent release of noradrenaline caused by anticancer drug 4′-epidoxorubicin in rat tail artery in vitro. Eur. J. Pharmacol., 356, 1998, č. 1, s. 25-30.
21. Semrád, B., Honzíková, N., Fišer, B.: Metody určení rizika náhlé srdeční smrti u nemocných po infarktu myokardu. Cor Vasa, 36. 1994, č. 6, s. 295-298.
22. Semrád, B., Fiśer, B., Honzíková, N.: Ageing and cardiac autonomic status. In: Clinical Guide to Cardiac Autonomic Tests. Ed. M. Malik. Dordrecht, Boston, London. Kluwer Academic Publishers 1998, s. 285-300.
23. Smyth, H. S., Sleight, P., Pickering, G. W.: Reflex regulation of arterial pressure during sleep in man: A quantitative method of assessing baroreflex sensitivity. Circ. Res., 3, 1969, s. 476-485.
24. Steinherz, L. J., Graham, T., Hurwitz, R., Sondheimer, H. M., Schwartz, R. G., Shaffer, E. M., Sandor, G., Benson, L., Williams, R.: Guidelines for cardiac monitoring of children during and after anthracydine therapy: report of the Cardiology Committee of the Childrens Cancer Study Group. Pediatrics, 89, 1992, č. 5, s. 942-949.
25. 2+ release from sarcoplasmic reticulum and contractile protein function in 'chemically-skinned' rabbit ventricular trabeculae. Jpn. J. Pharmacol., 76, 1998, č. 4, s. 405-413.